Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,379 | 419 | 40.5% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $6,000 | 6 | 29.0% |
| Honoraria | $3,000 | 3 | 14.5% |
| Travel and Lodging | $1,708 | 4 | 8.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,516 | 2 | 7.3% |
| Education | $76.00 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| LivaNova USA, Inc. | $8,004 | 18 | $0 (2021) |
| Cyberonics, Inc. | $5,194 | 10 | $0 (2017) |
| SK Life Science, Inc. | $1,105 | 45 | $0 (2024) |
| UCB, Inc. | $605.49 | 30 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $600.02 | 61 | $0 (2023) |
| ABBVIE INC. | $597.46 | 34 | $0 (2024) |
| Lilly USA, LLC | $580.62 | 33 | $0 (2024) |
| Horizon Therapeutics plc | $388.51 | 16 | $0 (2023) |
| Eisai Inc. | $312.94 | 16 | $0 (2024) |
| Avanir Pharmaceuticals, Inc. | $227.95 | 15 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $903.29 | 32 | SK Life Science, Inc. ($237.52) |
| 2023 | $769.81 | 32 | SK Life Science, Inc. ($257.18) |
| 2022 | $1,294 | 65 | SK Life Science, Inc. ($219.38) |
| 2021 | $3,220 | 84 | LivaNova USA, Inc. ($1,640) |
| 2020 | $1,062 | 70 | Allergan, Inc. ($140.78) |
| 2019 | $5,832 | 44 | LivaNova USA, Inc. ($5,184) |
| 2018 | $614.24 | 44 | Supernus Pharmaceuticals, Inc. ($211.75) |
| 2017 | $6,983 | 65 | Cyberonics, Inc. ($5,194) |
All Payment Transactions
436 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/14/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $31.53 | General |
| Category: Neurology | ||||||
| 12/11/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $33.89 | General |
| 12/04/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: Neuroscience | ||||||
| 11/22/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $32.81 | General |
| Category: Neurology | ||||||
| 11/13/2024 | Biogen, Inc. | LEQEMBI (Drug) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: Neurology | ||||||
| 10/21/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $29.87 | General |
| Category: Neurology | ||||||
| 10/14/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $31.66 | General |
| Category: Neurology | ||||||
| 10/08/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $33.89 | General |
| 09/19/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $32.89 | General |
| 09/10/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: Neuroscience | ||||||
| 09/06/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $41.02 | General |
| Category: Neurology | ||||||
| 09/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: PAIN | ||||||
| 08/01/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $37.33 | General |
| 06/19/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: NEUROLOGY | ||||||
| 06/10/2024 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: Neuroscience | ||||||
| 06/06/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $25.44 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/17/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $27.48 | General |
| Category: Neuroscience | ||||||
| 05/15/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: NEUROSCIENCE | ||||||
| 05/08/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: NEUROLOGY | ||||||
| 04/30/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $33.63 | General |
| 04/18/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $29.82 | General |
| Category: Inflammation/Rare Disease | ||||||
| 04/16/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $28.61 | General |
| Category: Central Nervous System | ||||||
| 04/02/2024 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Neuroscience | ||||||
| 03/20/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $32.84 | General |
| Category: NEUROLOGY | ||||||
| 03/14/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $31.54 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 598 | 993 | $665,119 | $130,843 |
| 2022 | 23 | 624 | 959 | $466,483 | $112,157 |
| 2021 | 16 | 606 | 1,058 | $560,560 | $148,713 |
| 2020 | 18 | 998 | 1,701 | $1.1M | $238,576 |
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95715 | Measurement of brain wave activity with video (veeg), 12-26 hours with intermittent monitoring | Office | 2023 | 23 | 69 | $380,700 | $42,372 | 11.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 99 | 319 | $41,680 | $21,737 | 52.2% |
| 95813 | Measurement of brain wave activity (eeg), 61-119 minutes | Office | 2023 | 35 | 36 | $19,800 | $10,765 | 54.4% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Office | 2023 | 23 | 70 | $35,000 | $10,674 | 30.5% |
| 95712 | Measurement of brain wave activity with video (veeg), 2-12 hours with intermittent monitoring | Office | 2023 | 23 | 23 | $92,000 | $7,985 | 8.7% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 20 | 23 | $8,050 | $4,809 | 59.7% |
| 95700 | Measurement of brain wave activity (eeg), continuous | Office | 2023 | 23 | 24 | $28,800 | $4,087 | 14.2% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 20 | 37 | $7,250 | $3,358 | 46.3% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Office | 2023 | 30 | 32 | $9,600 | $3,202 | 33.4% |
| 95812 | Measurement of brain wave activity (eeg), 41-60 minutes | Office | 2023 | 12 | 12 | $4,800 | $2,927 | 61.0% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 20 | 41 | $6,150 | $2,892 | 47.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 20 | $3,600 | $2,334 | 64.8% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 16 | 16 | $4,800 | $2,070 | 43.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $2,770 | $1,894 | 68.4% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 20 | 20 | $3,850 | $1,772 | 46.0% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 12 | 12 | $3,000 | $1,761 | 58.7% |
| 95921 | Testing of autonomic nervous system function and heart rate response to deep breathing | Office | 2023 | 20 | 20 | $2,000 | $1,273 | 63.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 22 | $2,090 | $1,162 | 55.6% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 20 | 20 | $3,600 | $1,115 | 31.0% |
| 96116 | Exam of neurobehavioral status, first hour | Office | 2023 | 13 | 13 | $1,274 | $908.70 | 71.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 20 | 23 | $1,495 | $907.50 | 60.7% |
| 93041 | Electrocardiogram (ecg) 1 to 3 leads | Office | 2023 | 56 | 79 | $1,975 | $328.64 | 16.6% |
| 98966 | Telephone medical discussion provided by nonphysician professional, 5-10 minutes | Office | 2023 | 20 | 23 | $355.00 | $227.01 | 63.9% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 12 | 14 | $350.00 | $172.90 | 49.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 12 | 13 | $130.00 | $109.20 | 84.0% |
About Dr. Rosa Bell, MD
Dr. Rosa Bell, MD is a Specialist healthcare provider based in Montgomery, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/16/2007. The National Provider Identifier (NPI) number assigned to this provider is 1891829073.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rosa Bell, MD has received a total of $20,679 in payments from pharmaceutical and medical device companies, with $903.29 received in 2024. These payments were reported across 436 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($8,379).
As a Medicare-enrolled provider, Bell has provided services to 2,826 Medicare beneficiaries, totaling 4,711 services with total Medicare billing of $630,290. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Montgomery, AL
- Active Since 03/16/2007
- Last Updated 07/08/2007
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1891829073
Products in Payments
- VNS Therapy (Device) $10,558
- VNS - Sentiva (Device) $1,640
- Voyager Vest (Device) $1,000
- TROKENDI XR (Drug) $449.14
- UBRELVY (Drug) $438.24
- EMGALITY (Drug) $395.30
- UPLIZNA (Drug) $388.51
- Briviact (Drug) $334.61
- QULIPTA (Drug) $288.25
- NURTEC ODT (Drug) $256.71
- Fycompa (Drug) $212.53
- ACTHAR (Biological) $201.00
- AMYVID (Drug) $185.32
- NUEDEXTA (Drug) $171.00
- Fintepla (Drug) $166.89
- Horizant (Drug) $161.49
- OXTELLAR XR (Drug) $150.88
- AUBAGIO (Drug) $149.90
- EPIDIOLEX (Drug) $132.85
- OCREVUS (Biological) $128.42
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Montgomery
Dr. John Robertson, M.d, M.D
Specialist — Payments: $15,644
Dr. Stephen Owens, M.d, M.D
Specialist — Payments: $10,634
Dr. Patrick Budny, M.d, M.D
Specialist — Payments: $8,612
Dr. Michael Bentley, M.d, M.D
Specialist — Payments: $7,374
Rafael Lopez, M.d, M.D
Specialist — Payments: $5,281
Timothy Morrow, M.d, M.D
Specialist — Payments: $2,741